<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02622139</url>
  </required_header>
  <id_info>
    <org_study_id>252_15B</org_study_id>
    <nct_id>NCT02622139</nct_id>
  </id_info>
  <brief_title>Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)</brief_title>
  <acronym>MSOT_IBD</acronym>
  <official_title>Monocentric, Prospective Interventional Study to Assess the Degree of Disease Activity With a Multispectral Optoacoustic Tomography (MSOT) Handheld Scanner in Patients With Crohn's Disease or Ulcerative Colitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>iThera Medical GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Monocentric, prospective interventional study to assess the degree of disease activity with a
      multispectral optoacoustic tomography (MSOT) handheld scanner in patients with Crohn's
      disease or ulcerative colitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed study is designed as a pilot study to evaluate the usefulness of MSOT for the
      evaluation of disease activity in IBD patients. As current methods for the evaluation of
      intestinal inflammation in IBD have relevant restrictions, new, non-invasive, quantitative,
      and accurate modalities are urgently needed. In comparison to other techniques, MSOT provides
      relevant advantages such as non-invasive imaging, high spatial resolution (this is of special
      importance for the evaluation of the intestine, which can be only a few millimeters thick),
      and highly sensitive detection of specific molecules such as total hemoglobin or oxy-
      /deoxygenated hemoglobin. These advantages suggest MSOT as an outstanding technique for
      evaluating disease activity in IBD.

      The proposed study incorporates nearly no risk for participating patients and might provide
      relevant data for more a more in depth analysis of MSOT for IBD diagnosis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of MSOT-data with clinical activity scores of IBD</measure>
    <time_frame>12 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation of MSOT-data with sonographic parameters</measure>
    <time_frame>12 month</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">344</enrollment>
  <condition>Crohn's Disease</condition>
  <condition>Ulcerative Colitis</condition>
  <condition>IBD</condition>
  <arm_group>
    <arm_group_label>Multispectral Optoacoustic Tomography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multispectral Optoacoustic Tomography (MSOT) for the evaluation of disease activity in inflammatory bowel diseases (IBD)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Multispectral Optoacoustic Tomography (MSOT)</intervention_name>
    <description>MSOT for the evaluation of disease activity in IBD patients</description>
    <arm_group_label>Multispectral Optoacoustic Tomography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histological verified Crohn's disease or ulcerative colitis

          -  Age &gt; 18 years

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Mental retardation of the patient with restriction of general judgment and awareness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maximilian Waldner, MD</last_name>
    <email>maximilian.waldner@uk-erlangen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ferdinand Knieling, MD</last_name>
    <email>ferdinand.knieling@uk-erlangen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical Department 1, University of Erlangen-Nürnberg</name>
      <address>
        <city>Erlangen</city>
        <state>Bavaria</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maximilian Waldner, MD</last_name>
      <email>maximilian.waldner@uk-erlangen.de</email>
    </contact>
    <contact_backup>
      <last_name>Ferdinand Knieling, MD</last_name>
      <email>ferdinand.knieling@uk-erlangen.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2015</study_first_submitted>
  <study_first_submitted_qc>December 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2015</study_first_posted>
  <last_update_submitted>January 11, 2017</last_update_submitted>
  <last_update_submitted_qc>January 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Photoacoustics</keyword>
  <keyword>Optoacoustics</keyword>
  <keyword>Ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

